Data regarding BCMA expression on other B-cell malignancies are scarce, and for CLL, DLBCL, follicular lymphoma, and MCL conflicting reports have been published (17, 24–27), which complicated the question whether BCMA is a feasible target in these diseases. The gene discussed is TNFRSF17; the disease is diffuse large B-cell lymphoma.